Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
With regard to Cerebral Venous Thrombosis (CVT) importance as a life threatening disease,
specific care is necessary, Known anti-coagulants have limitations.Vitamin K antagonists such
as Warfarin, require laboratory monitoring and exact administration starting and maintenance
dose. although Rivaroxaban(selective and direct Xa factor antagonist ) has no monitoring and
no drug interaction. This study aim to focus on efficacy of Warfarin versus Rivaroxaban.